Rockwell Automation announces the latest version of its leading Enterprise Production Management (EPM) software focused on the life sciences industry Propack Data PMX MES 4.1. The new version supports cost-effective, risk-based manufacturing approaches through fast electronic batch record reviews, flexible and controlled operator work instructions, and on-demand views of production information from raw material receipt through product release. "Todays life sciences companies are looking beyond blockbuster drugs and patent protection and into manufacturing operations for strategic advantages," said Robert Honor, life sciences vice president, Rockwell Automation. "With Propack Data PMX MES software, companies can optimize operations in line with the FDAs risk-based approach, making manufacturing capabilities a competitive advantage." The newest version provides extended equipment and material flow capabilities to track and manage raw materials, work-in-process and final products. With browser-based clients and seamless integration to Rockwell Software RSBizWare Batch, Rockwell Software RSBizWare Historian and third party batch and historian systems, users can access comprehensive manufacturing information on-demand and fast-track electronic batch record reviews. Propack Data PMX MES also is validation-ready for rapid, compliant-ready implementations and overall lower total cost of ownership. Propack Data PMX MES software is a key element in the complete Rockwell Automation Enterprise Production Management (EPM) suite designed to help improve product quality and safety, increase efficiency and assist with regulatory compliance. The complete EPM suite provides extensive capabilities for manufacturing execution, clinical supply management, batch management, line performance and monitoring and complete automation across clinical, primary and secondary operations.
Quantifying technology’s impact on vaccination rates
Sept. 9, 2022
Unlocking the full potential of pharma batch reports
Aug. 12, 2022
Shortening the equipment qualification path
June 20, 2022
Circling back to digital initiatives in pharma
June 15, 2022